Welcome to our dedicated page for Cannabix Technol news (Ticker: BLOZF), a resource for investors and traders seeking the latest updates and insights on Cannabix Technol stock.
Cannabix Technologies Inc. develops marijuana and alcohol breath-testing technologies for workplace safety, law enforcement, and other safety-sensitive settings. Company news centers on the Marijuana Breath Test, or MBT, including its Breath Collection Unit and single-use Breath Cartridges used to collect breath samples for laboratory analysis of recent cannabis use.
Recurring updates include commercial rollout activity, deliveries through authorized resellers, product validation, regulatory and compliance testing for device hardware, and distribution or education efforts with testing-industry partners. News also covers the company’s work with Omega Laboratories on analytical methods for detecting cannabinoids in breath samples using LC-MS-based testing.
Cannabix Technologies (OTC:BLOZF) reported detection of cocaine and its metabolite benzoylecgonine in human breath using its Marijuana Breath Test (MBT) system. Samples were collected with the Cannabix Breath Collection Unit and analyzed by Omega Laboratories via LC‑MS.
The company believes this supports broader multi-drug breath testing applications across workplace, transportation, industrial, rehabilitation, and law enforcement markets.
Cannabix Technologies (OTC: BLOZF) reported successful detection of methamphetamine and amphetamine in human breath using its Marijuana Breath Test (MBT) system. Breath samples collected with the Cannabix Breath Collection Unit were analyzed by Omega Laboratories using LC-MS, demonstrating MBT sensitivity beyond THC.
The company believes capturing amphetamine-class stimulants at trace breath concentrations could expand applications in workplace safety, transportation, industrial settings, and law enforcement for non-invasive, scientifically defensible drug testing solutions.
Cannabix Technologies (OTC:BLOZF) announced its first deployment of BreathLogix alcohol screening devices in Africa via a Senegal-based distributor serving large mining operations. Units are destined for mining sites to support pre-shift, access control, and safety compliance testing.
BreathLogix is an automated, unmanned system that delivers BAC/BrAC readings, identity-verified testing, real-time SMS/email alerts, and cloud-based data management through BreathLogix Connect, and can integrate with gates, turnstiles, and fleet management for scalable workplace alcohol safety programs.
Cannabix Technologies (OTC:BLOZF) announced deployment of its Marijuana Breath Test (MBT) with a major heavy-materials industrial operator in Québec, delivered via Alco Prevention Canada.
The MBT supports post-incident and reasonable-cause workplace testing, focusing on recent cannabis use with non-invasive breath collection and lab-confirmed LC-MS analysis to aid safety, policy defensibility, and incident response.
Cannabix Technologies (OTC: BLOZF) announced deployment of its BreathLogix automated alcohol screening systems with mining, municipal and aviation clients in Australia via exclusive distributor Breathalyser Sales & Service. BreathLogix provides unmanned, rapid breath testing, identity-linked BAC/BrAC readings, real-time alerts, and cloud-based compliance tracking across multiple sites and access-control systems.
Cannabix Technologies (OTC: BLOZF) announced its Marijuana Breath Test Breath Collection Unit (BCU) has secured UL 61010-1 (U.S.) and CSA 61010-1-12 (Canada) electrical safety certifications. Testing was completed at an ISO/IEC 17025 accredited lab, supporting commercialization of the MBT system in workplace, industrial, and law enforcement settings.
Cannabix Technologies (OTCID: BLOZF) delivered its Marijuana Breath Test (MBT) devices to a workplace drug and alcohol testing clinic serving eastern Canada on May 4, 2026. The delivery, completed via an authorized reseller, targets clinics seeking breath-based THC tools for recent-use assessment, non-invasive collection, and LC-MS lab confirmation.
The company positions MBT for post-incident, reasonable-cause, deterrence, and fitness-for-duty applications as clinics seek more timely, defensible testing than legacy urine or oral-fluid methods.
Cannabix Technologies (OTCID: BLOZF) announced that strategic partner Omega Laboratories will present the Cannabix Marijuana Breath Test (MBT) and host two educational panels at the NDASA Conference, April 26–29, 2026, in Orange County, California.
The MBT targets detection of delta-9 THC in breath within 4 hours of consumption and is designed for recent-use workplace screening.
Cannabix Technologies (OTCID: BLOZF) announced commercial delivery of its Marijuana Breath Test (MBT) to a Virginia industrial manufacturing client on April 1, 2026, completed via an authorized reseller.
The MBT detects delta-9 THC in breath within four hours above 5 pg/L, uses proprietary Breath Collection Unit and laboratory LC-MS analysis, and leverages a strategic partnership with Omega Laboratories.
Cannabix Technologies (OTCID: BLOZF) announced the first commercial delivery of its Marijuana Breath Test (MBT) to a major construction contractor on March 19, 2026. The MBT detects delta-9 THC in breath within approximately four hours at levels above 5 pg/L and uses single-use Breath Cartridges plus a Breath Collection Unit.
The company partners with Omega Laboratories for LC-MS laboratory analysis and plans to scale production through resellers targeting safety-sensitive sectors such as construction, transportation, and manufacturing.